FindTrial
Sign In

Construction and Validation of a Predictive Model for the Onset and Progression of Metabolic Dysfunction-Associated Fatty Liver Disease

Construction and Validation of a Predictive Model for the Onset and Progression of Metabolic Dysfunction-Associated Fatty Liver Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098553
Enrollment
Unknown
Registered
2025-03-10
Start date
2025-03-30
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Dysfunction-Associated Fatty Liver Disease

Interventions

Observation group:None

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age>=18 years; (2) voluntarily participate in this study; (3) Those who have completed questionnaires, general examinations, hematological examinations, body composition examinations, abdominal ultrasounds/liver elasticity measurements.

Exclusion criteria

Exclusion criteria: (1) Age< 18 years old; (2) incomplete data; (3) the presence of severe systemic diseases; (4) Patients with autoimmune hepatitis, drug-induced hepatitis, and acute infection; (5) pregnant and lactating women; (6) Participate in other interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
Fat-Free Mass Index; FFMI;Skeletal Muscle Mass Index, SMI;Appendicular Muscle Mass Index, AMI;Insulin resistance indicator;—

Countries

China

Contacts

Public ContactYanping Feng

Beijing Jishuitan Hospital, Capital Medical University

fypv022025@126.com+86 188 1067 0329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026